Resource and Technical AdvanceIn-Press PreviewClinical ResearchImmunologyInfectious disease
Open Access |
10.1172/jci.insight.204610
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by DuBois, A. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Ankomah, P. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Campbell, A. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Hua, R. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Nelson, O. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Zeuthen, C. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Das, M. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Mann, S. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Mauermann, A. in: PubMed | Google Scholar
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by
Parry, B.
in:
PubMed
|
Google Scholar
|
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by
Shapiro, N.
in:
PubMed
|
Google Scholar
|
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by
Filbin, M.
in:
PubMed
|
Google Scholar
|
1Infectious Disease and Microbiome Program, Broad Institute, Cambridge, United States of America
2Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States of America
3Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America
Find articles by Bhattacharyya, R. in: PubMed | Google Scholar
Published July 14, 2026 - More info
Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) has enhanced our understanding of host immune mechanisms in small cohorts, particularly in diseases with complex and heterogeneous immune responses such as sepsis. However, standard PBMC isolation from blood requires technical expertise and over two hours of onsite processing using Ficoll density gradient separation (‘Ficoll’) for scRNA-seq compatibility, precluding large-scale sample collection at most clinical sites. To minimize onsite processing, we developed Cryo-PRO (Cryopreservation with PBMC Recovery Offsite), a method of immediate onsite whole blood cryopreservation and subsequent batched PBMC isolation in a central laboratory prior to sequencing. We compared multimodal single-cell immune profiling results from samples processed using Cryo-PRO versus standard onsite Ficoll separation in 23 patients with sepsis. Critical outputs including cell substate fractions, marker genes, and surface protein expression were similar for each method across multiple cell types and substates, including an important monocyte substate enriched in patients with sepsis. Capture of T cell receptor transcripts was also comparable across both methods. Cryo-PRO reduced onsite sample processing time from >2 hours to <15 minutes and was reproducible across two enrollment sites, thus demonstrating potential for expanding multimodal single-cell analyses in multicenter studies of sepsis and other diseases.